Keep up-to-date with the latest access to medicines news and research, plus interviews and opinion from our partners and other experts, and videos and photo stories of our work.
News
-
COVID-19 vaccine announcements: Our view
Following on from the BioNTech and Pfizer vaccine announcement earlier this month, where we expressed cautious optimism, but also the...
-
Who will get Pfizer’s COVID-19 vaccine?
BioNTech and Pfizer have announced today that their vaccine candidate has, so far, been found to be more than 90%...
-
Russian government advised – “issue compulsory license to make generic COVID-19 drug available”
First civil society, and now a generic drug company, have asked the Russian government to issue a compulsory license on...
-
Andrei: “The church and HIV treatment activism go hand-in-hand”
Interviewed by Gemma Taylor. “I’m never apart from this book, it’s what inspires me,” says Andrei, 44, a black leather...
-
TB: 9 patent oppositions against J&Js overpriced drugs
1.2 million lives were lost to TB last year. The reduction in TB deaths annually is slow, and even these...
-
COVID-19 & TB: Why whether you live or die is a matter of justice, not science
Johnson & Johnson, a brand built on images of happy gurgling babies and the tagline ‘no more tears’, has the...
-
HIV2020 video: Community reclaiming the global response!
The Treatment Activist Meeting took place last week, as part of HIV2020 Online. HIV2020 is described as a key population-led, inter-disciplinary,...
-
Join the #HIV2020 Activist Meeting – this Tuesday
Please join us at the HIV2020 Treatment Activist Meeting on Tuesday 6th October! Register by Sunday 4th October. The history of the HIV...
-
HIV: Switch to generic darunavir in Kyrgyzstan and save $53,000
First published by the Partnership Network Association in Kyrgyzstan, read here in Russian. Analysis carried out by our campaign partner,...
-
Indian Patent Office: Merck’s patent application for HIV drug, raltegravir, is “refused”
A patent that Merck has been pursuing in India since 2007 has been refused by the Indian Patent Office. The...
-
Petro: Providing the protection he didn’t have
When Petro was a teenager selling sex, HIV treatment didn’t exist, at least not as far as he was aware,...
-
Russian patient organizations ask Gilead to disclaim patents for Truvada
On 3 September 2020, 25 patient organizations working within the HIV response in Russia published an open letter to Gilead...